A first national prevalence estimate of diagnosed and undiagnosed diabetes in France in 18- to 74-year-old individuals: The French Nutrition and Health Survey 2006/2007

Diabetic Medicine

Volumn 28, Issue 5, 2011, Pages 583-589

  Bonaldi, C ^a   Vernay, M ^b   Roudier, C ^b   Salanave, B ^b   Oleko, A ^b   Malon, A ^b   Castetbon, K ^b   Fagot Campagna, A ^a  

^a French Institute for Public Health Surveillance   (France)

^b UNIVERSITÉ PARIS 13   (France)

Author keywords

Diagnosed and undiagnosed diabetes; Epidemiology; Fasting plasma glucose; HbA1c; Prevalence

Indexed keywords

ANTIDIABETIC AGENT; GLUCOSE; HEMOGLOBIN A1C;

ADULT; AGED; ARTICLE; BIOCHEMISTRY; DIABETES MELLITUS; DIET RESTRICTION; FEMALE; FRANCE; GLUCOSE BLOOD LEVEL; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; NUTRITIONAL PARAMETERS; PREVALENCE; SELF REPORT;

ADOLESCENT; ADULT; AGED; DIABETES MELLITUS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; FRANCE; HEALTH SURVEYS; HUMANS; MALE; MIDDLE AGED; PREDIABETIC STATE; PREVALENCE; PROBABILITY; QUESTIONNAIRES; YOUNG ADULT;

EID: 79954458000     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2011.03250.x     Document Type: Article

References (31)

1. International Diabetes Federation. Diabetes Atlas, 3rd edn. Brussels: Delice Gan Eds, 2006.
2. Romon I, Jougla E, Balkau B, Fagot-Campagna A. The burden of diabetes-related mortality in France in 2002: an analysis using both underlying and multiple causes of death. Eur J Epidemiol 2008; 23: 327-334.
3. Zimmet P, Alberti KG, Shaw J. Global and societal implications of the diabetes epidemic. Nature 2001; 414: 782-787.
4. Schulze MB, Hu FB. Primary prevention of diabetes: what can be done and how much can be prevented? Annu Rev Public Health 2005; 26: 445-467.
5. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004; 27: 1047-1053.
6. Kusnik-Joinville O, Weill A, Ricordeau P, Allemand H. Diabète traité en France en 2007 un taux de prévalence proche de 4 % et des disparités géographiques croissantes (Treated diabetes in France in 2007: a prevalence rate close to 4% and increasing geographic disparities). Bull Epidemiol Hebdo 2008; 43: 409-413. Available at Last accessed 27 April 2010.
7. Gonzalez EL, Johansson S, Wallander MA, Rodriguez LA. Trends in the prevalence and incidence of diabetes in the UK: 1996-2005. J Epidemiol Community Health 2009; 63: 332-336.
8. Carstensen B, Kristensen JK, Ottosen P, Borch-Johnsen K. The Danish National Diabetes Register: trends in incidence, prevalence and mortality. Diabetologia 2008; 51: 2187-2196.
9. Baan CA, Schoemaker CG, Jacobs-van der Bruggen MAM, Hamberg-van Reenen HH, Verkleij H, Heus S, Melse JM. Diabetes tot 2025. Preventie en zorg in samenhang (Diabetes in the Netherlands 2007-2025. Prevention and care in cohesion). Bilthoven: Rijksinstituut voor Volksgezondheid en Milieu, 2009. Available at Last accessed 19 August 2009.
10. Cowie CC, Rust KF, Ford ES, Eberhardt MS, Byrd-Holt DD, Li C et al. Full accounting of diabetes and pre-diabetes in the US population in 1988-1994 and 2005-2006. Diabetes Care 2009; 32: 287-294.
11. Balkau B. The DECODE study. Diabetes epidemiology: collaborative analysis of diagnostic criteria in Europe. Diabetes Metab 2000; 26: 282-286.
12. Castetbon K, Vernay M, Malon A, Salanave B, Deschamps V, Roudier C et al. Dietary intake, physical activity and nutritional status in adults: the French nutrition and health survey (ENNS, 2006-2007). Br J Nutr 2009; 102: 733-743.
13. Brussaard JH, Löwik MR, Steingrímsdóttir L, Møller A, Kearney J, De Henauw S et al. A European food consumption survey method-conclusions and recommendations. Eur J Clin Nutr 2002; 56: S89-S94.
14. WHO. Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications: Report of a WHO Consultation. Geneva: World Health Organization, 1999.
15. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 2003; 26: S5-S20.
16. 1c assay in the diagnosis of diabetes. Diabetes Care 2009; 32: 1327-1334.
17. Lecomte P, Vol S, Caces E, Lasfargues G, Combe H, Laurent S et al. Impaired fasting glycaemia and undiagnosed diabetes: prevalence, cardiovascular and behavioural risk factors. Diabetes Metab 2002; 28: 311-320.
18. Bourdel-Marchasson I, Helmer C, Barberger-Gateau P, Peuchant E, Fevrier B, Ritchie K et al. Characteristics of undiagnosed diabetes in community-dwelling French elderly: the 3C study. Diabetes Res Clin Pract 2007; 76: 257-264.
19. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998; 15: 539-553.
20. Charles MA, Simon D, Balkau B, Eschwege E. Révision des critères diagnostiques du diabète. Les raisons et les conséquences. (Revision of diagnostic criteria of diabetes. The reasons and the consequences). Diabetes Metab 1998; 24: 75-79.
21. Rathmann W, Haastert B, Icks A, Lowel H, Meisinger C, Holle R et al. High prevalence of undiagnosed diabetes mellitus in Southern Germany: target populations for efficient screening. The KORA survey 2000. Diabetologia 2003; 46: 182-189.
22. Thomas MC, Walker MK, Emberson JR, Thomson AG, Lawlor DA, Ebrahim S et al. Prevalence of undiagnosed Type2 diabetes and impaired fasting glucose in older British men and women. Diabet Med 2005; 22: 789-793.
23. Pierce MB, Zaninotto P, Steel N, Mindell J. Undiagnosed diabetes-data from the English longitudinal study of ageing. Diabet Med 2009; 26: 679-685.
24. The Information Centre/NHS. National Diabetes Audit - Executive summary. Key findings about the quality of care for people with diabetes in England and Wales. Report for the audit period 2007-2008. London: The Information Center/NHS, 2009. Available at Last accessed 2 June 2010.
25. Forouhi NG, Merrick D, Goyder E, Ferguson BA, Abbas J, Lachowycz K et al. Diabetes prevalence in England, 2001-estimates from an epidemiological model. Diabet Med 2006; 23: 189-197.
26. YHPHO. PBS Diabetes Prevalence Model Phase3: Key Findings. York: Yorkshire and Humber Public Health Observatory, 2008. Available at Last accessed 2 June 2010.
27. Cowie CC, Rust KF, Byrd-Holt DD, Eberhardt MS, Flegal KM, Engelgau MM et al. Prevalence of diabetes and impaired fasting glucose in adults in the US population. Diabetes Care 2006; 29: 1263-1268.
28. Allonier C, Dourgnon P, Rochereau T. Enquête sur la santé et la protection sociale 2008 (The French Health, Health Care and Insurance Survey 2008). Paris: Institut de recherche et documentation en économie de la santé, 2010. Available at Last accessed 18 October 2010.
29. Hirtzlin I, Fagot-Campagna A, Girard-Le Gallo I, Vallier N, Poutignat N, Weill A et al. Dépistage du diabéte les données de l'Échantillon Permanent des Assurés Sociaux, 2000-2001 (Screening for diabetes in France: data from the 2000-2001 cohort of the national medical insurance system). Rev Epidemiol Sante Publique 2004; 52: 119-126.
30. ANAES. Principes de depistage du diabète de type2 (Principles of Type 2 diabetes screening). Paris: Agence Nationale d'Accréditation et d'Evaluation en Santé, 2003. Available at Last accessed 1 October 2009.
31. UK Prospective Diabetes Study. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type2 diabetes: UKPDS33. Lancet 1998; 352: 837-853.